Bifogade filer
Kurs
-2,01%
Likviditet
0,01 MSEK
Kalender
Est. tid* | ||
2025-10-17 | N/A | X-dag ordinarie utdelning PHI 0.00 SEK |
2025-10-16 | N/A | Årsstämma |
2025-09-26 | 12:30 | Kvartalsrapport 2026-Q1 |
2025-07-11 | N/A | Extra Bolagsstämma 2025 |
2025-06-26 | - | Bokslutskommuniké 2025 |
2025-03-13 | - | Kvartalsrapport 2025-Q3 |
2024-11-28 | - | Kvartalsrapport 2025-Q2 |
2024-10-12 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2024-09-16 | - | Kvartalsrapport 2025-Q1 |
2024-06-26 | - | Bokslutskommuniké 2024 |
2024-03-27 | - | Kvartalsrapport 2024-Q3 |
2023-12-21 | - | Kvartalsrapport 2024-Q2 |
2023-11-15 | - | Extra Bolagsstämma 2024 |
2023-10-27 | - | Årsstämma |
2023-10-13 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2023-09-20 | - | Kvartalsrapport 2024-Q1 |
2023-06-23 | - | Bokslutskommuniké 2023 |
2023-05-09 | - | Extra Bolagsstämma 2023 |
2023-03-28 | - | Kvartalsrapport 2023-Q3 |
2022-12-21 | - | Kvartalsrapport 2023-Q2 |
2022-10-31 | - | Årsstämma |
2022-10-14 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2022-09-29 | - | Kvartalsrapport 2023-Q1 |
2022-06-29 | - | Bokslutskommuniké 2022 |
2022-03-21 | - | Kvartalsrapport 2022-Q3 |
2022-03-15 | - | Extra Bolagsstämma 2022 |
2021-12-29 | - | Kvartalsrapport 2022-Q2 |
2021-10-20 | - | Extra Bolagsstämma 2021 |
2021-10-11 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2021-09-29 | - | Kvartalsrapport 2022-Q1 |
2021-06-24 | - | Bokslutskommuniké 2021 |
2021-03-16 | - | Kvartalsrapport 2021-Q3 |
2020-12-14 | - | Kvartalsrapport 2021-Q2 |
2020-10-20 | - | Årsstämma |
2020-10-15 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2020-09-28 | - | Kvartalsrapport 2021-Q1 |
2020-06-25 | - | Bokslutskommuniké 2020 |
2020-03-12 | - | Kvartalsrapport 2020-Q3 |
2019-12-17 | - | Kvartalsrapport 2020-Q2 |
2019-10-16 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2019-10-15 | - | Årsstämma |
2018-09-27 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2018-09-26 | - | Årsstämma |
2018-06-18 | - | Extra Bolagsstämma 2019 |
2018-06-12 | - | Bokslutskommuniké 2018 |
2018-03-12 | - | Kvartalsrapport 2018-Q3 |
2017-09-26 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2017-09-25 | - | Årsstämma |
2017-09-11 | - | Kvartalsrapport 2018-Q1 |
2017-06-19 | - | Bokslutskommuniké 2017 |
2017-03-13 | - | Kvartalsrapport 2017-Q3 |
2017-01-01 | - | Extra Bolagsstämma 2018 |
2016-11-30 | - | Kvartalsrapport 2017-Q2 |
2016-09-06 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2016-09-05 | - | Årsstämma |
2016-09-05 | - | Kvartalsrapport 2017-Q1 |
2016-06-13 | - | Bokslutskommuniké 2016 |
2016-02-22 | - | Kvartalsrapport 2016-Q3 |
2016-02-16 | - | Extra Bolagsstämma 2017 |
2015-11-30 | - | Kvartalsrapport 2016-Q2 |
2015-09-08 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2015-09-07 | - | Årsstämma |
2015-09-07 | - | Kvartalsrapport 2016-Q1 |
2015-06-16 | - | Bokslutskommuniké 2015 |
2015-03-16 | - | Kvartalsrapport 2015-Q3 |
2014-12-01 | - | Kvartalsrapport 2015-Q2 |
2014-10-07 | - | X-dag ordinarie utdelning PHI 0.00 SEK |
2014-10-06 | - | Årsstämma |
2014-10-06 | - | Kvartalsrapport 2015-Q1 |
2014-06-30 | - | Bokslutskommuniké 2014 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
Phase Holographic Imaging PHI AB (publ), reg.no 556542-7811 (the "Company") held its annual general meeting on 31 October 2024. The following resolutions were made.
Adoption of the income statement and balance sheet
The annual general meeting resolved to adopt the board of directors' proposal for the income statement and the balance sheet for the fiscal year of 2023/24.
Disposition of the Company's profit or loss
The annual general meeting resolved, in accordance with the board of directors' proposal, that no dividend shall be paid and that the result for the year is carried forward.
Discharge from liability
The annual general meeting resolved to grant discharge from liability to all persons who have had the position of board member or CEO in the Company during the fiscal year 2023/24.
Election of members of the board of directors and auditor, and determination of fees
The annual general meeting resolved to re-elect Goran Dubravčić, Ivan Jorkovic, Mats Lundwall, Leland Foster, Petter Björquist, John Moore and Peter Egelberg as members of the board.
The annual general meeting resolved that fees to non-employed board members elected by the annual general meeting shall be paid with two (2) income base amounts (Sw. inkomstbasbelopp) to the chairman, with one (1) income base amount each to the other board members and with half (0,5) an income base amount to a deputy board member. It was further resolved that for any additional work efforts in addition to ordinary board work, board members shall be able to receive consulting fees in line with market practice.
The annual general meeting resolved to re-elect the authorised public accounting firm Mazars AB as the Company's auditor for the period until the next annual general meeting. Mazars AB has announced that the authorised auditor Anders Persson will be appointed as auditor in charge. Fees to the auditor shall be paid according to approved invoice.
Amendment of the articles of association
The annual general meeting resolved to change the Company's permitted minimum share capital from SEK 2,400,000 to SEK 5,000,000 and to increase the maximum permitted maximum share capital from SEK 9,600,000 to SEK 20,000,000 by amending § 4 of the articles of association.
The annual general meeting further resolved to increase the Company's permitted minimum number of shares from 12,000,000 shares to 25,000,000 shares and the permitted maximum number of shares from 48,000,000 shares to 100,000,000 shares by amending § 5 of the articles of association.
Authorisation for the board of directors to resolve on the issue of shares, warrants and/or convertibles
The annual general meeting resolved to authorise the board of directors to, on one or more occasions, during the period until the next annual general meeting, decide to increase the Company's share capital by a maximum of SEK 785,787,6. The increase of the share capital may take place through a new issue of shares and/or convertibles and/or warrants entitling to conversion and subscription respectively of a total of 3,928,938 shares. The board of directors may decide on such issue with deviation from the shareholders' preferential rights and with a provision for cash payment and/or payment in kind, set-off or otherwise with conditions in accordance with Chapter 2, Section 5, second paragraph 1-3 and 5 of the Swedish Companies Act.
An issue in accordance with this authorisation shall be made at a market-based subscription price, subject to a market-based issue discount where applicable. The board of directors shall be entitled to determine the other terms and conditions for the issue in accordance with this authorisation and who shall be entitled to subscribe for new shares, convertibles and/or warrants.
Phase Holographic Imaging PHI AB (publ)
The Board of Directors
Lisa Bodily
E-mail: ir@phiab.com (ir@phiab.se)
Web: www.phiab.com - Live cell imaging & analysis